Forecast Bio, Inc.
PrivateLast Round
Accelerator
Mar 13, 2026
Total Funding Raised
$100,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Forecast Bio, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in March 2026.
Forecast Bio, Inc. is a biotechnology company developing an AI-powered preclinical platform that links cellular neurobiology to mental health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Workflow Automation, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forecast Bio, Inc. Comparables
Compare Forecast Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eratos Therapeutics | 83% | |
| Mindstate Design Labs | 83% | |
| Neuroblox | 82% |
For institutional investors. Book with your work email.
Forecast Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 13, 2026 | ||||
| Accelerator | Feb 9, 2026 | ||||
| Seed Round | Nov 11, 2025 | ||||
| Seed | Jul 15, 2025 |
For institutional investors. Book with your work email.
Forecast Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| One Mind | Accelerator |
| One Mind Accelerator | Seed |
| The Venture Collective | Accelerator |
| XEIA Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2026
$100K raised from The Venture Collective and others.
- Feb 9, 2026
Led by One Mind, a not-for-profit venture capital firm.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 19, 2026
Forecast is developing a research platform that combines three-dimensional human brain tissue models derived from stem cells, functional biological data, and machine learning to improve psychiatric drug development and evaluation in United States.
For institutional investors. Book with your work email.
Forecast Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Forecast Bio, Inc.'s valuation, stock price, and market status.
Is Forecast Bio, Inc. a public or private company?
Forecast Bio, Inc. is a private company.
What is the current stock price of Forecast Bio, Inc.?
Forecast Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Forecast Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Forecast Bio, Inc. worth (valuation)?
Valuation information for Forecast Bio, Inc. is not publicly available.
Can I buy Forecast Bio, Inc. stock?
Forecast Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Forecast Bio, Inc.'s last funding round?
Forecast Bio, Inc.'s most recent funding round was Accelerator on March 13, 2026.
Who are the main investors in Forecast Bio, Inc.?
Key investors in Forecast Bio, Inc. include One Mind.
Will Forecast Bio, Inc. IPO soon?
No public IPO plans have been announced for Forecast Bio, Inc..
How can I track Forecast Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Forecast Bio, Inc.'s shares on secondary markets.